Lv1
48 积分 2022-06-09 加入
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
1个月前
已完结
Ceramides: A Cause of Insulin Resistance in Nonalcoholic Fatty Liver Disease in Both Murine Models and Humans
2个月前
已完结
Plasma lecithin:cholesterol acyltransferase and phospholipid transfer protein activity independently associate with nonalcoholic fatty liver disease
4个月前
已完结
Pravastatin combination with sorafenib does not improve survival in advanced hepatocellular carcinoma
4个月前
已完结
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
4个月前
已完结
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
4个月前
已完结
Metabolic Dysfunction–Associated Steatotic Liver Disease
4个月前
已完结
MASLD and MASLD-associated HCC: emerging biomarkers and therapeutic avenues
5个月前
已关闭
A protein interaction landscape of breast cancer
5个月前
已完结
Effect of diabetes medications and glycemic control on risk of hepatocellular cancer in patients with nonalcoholic fatty liver disease
6个月前
已完结
皖公网安备34019202002308
